Pure Bioscience, Inc. (PURE)

[johnkenny]

Covid OTC company's or covid big players? PURE is in an uptrend like the others. Low volume and if someone wants out, its tanking. It was in the .20's to .50's for a long time. They shouldn't have to dilute with cash on hand and profitability. I would say the cure (vaccine) will bring them all lower unless your invested in the company that has the vaccine. The valuation is rich if they are breaking even but not if they are growing and hitting .20 annualized profits. The only shady thing is the CEO selling to another company he controls, but all otc has something.